… , safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy …
A Asatryan, N Meyer, M Scherbakov… - Human Vaccines & …, 2021 - Taylor & Francis
… safety of a single dose of dTpa vaccine in healthy Russian … ICH Harmonized Tripartite
Guideline for clinical investigation of … , acellular pertussis vaccine (Boostrix™) is immunogenic and …
Guideline for clinical investigation of … , acellular pertussis vaccine (Boostrix™) is immunogenic and …
… booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An …
M Kovac, L Kostanyan, N Mesaros… - Human Vaccines & …, 2018 - Taylor & Francis
Full article: Immunogenicity and safety of a second booster dose of an acellular pertussis
vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first …
vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first …
… I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in …
G Leroux-Roels, M Lattanzi, CD Solis… - Human Vaccines & …, 2018 - Taylor & Francis
… , reduced antigen content) vaccines, containing the genetically detoxified PT, as compared
… Boostrix is indicated for active booster immunization against TdaP as a single dose in …
… Boostrix is indicated for active booster immunization against TdaP as a single dose in …
[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …
FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
… and guidance regarding the use of Tdap vaccines (3). … Boostrix (GlaxoSmithKline) is approved
for a single dose in persons … booster dose of reduced antigen content diphtheria, tetanus, …
for a single dose in persons … booster dose of reduced antigen content diphtheria, tetanus, …
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4–65 years of age: A …
I Aydin, M May, F Pisano, N Mpofu-Maetzig, L Grode… - Vaccine, 2023 - Elsevier
… years received a single dose of either SIIPL Tdap or comparator Tdap vaccine (Boostrix®, …
Prior to discharge, subjects were provided with a thermometer and careful instructions were …
Prior to discharge, subjects were provided with a thermometer and careful instructions were …
Boosting teenagers with acellular pertussis vaccines containing recombinant or chemically inactivated pertussis toxin: a randomized clinical trial
G Blanchard Rohner, O Chatzis… - Clinical Infectious …, 2019 - academic.oup.com
… A single dose contains 5 μg of rPT and 5 μg of FHA… Tdap comparator (Boostrix) contains 8
μg of cdPT, 8 μg of FHA, 2.5 μg of pertactin, 20 IU of TT, and 2 IU of DT. All vaccines, adsorbed …
μg of cdPT, 8 μg of FHA, 2.5 μg of pertactin, 20 IU of TT, and 2 IU of DT. All vaccines, adsorbed …
… pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) …
N Sompagdee, S Anuwutnavin, W Phongsamart… - Vaccine, 2020 - Elsevier
… DT, ≥ 5 Lf of TT, and absorbed on 1.25 mil (mg) of aluminum … manufacturer’s instructions.
ELISA kit controls were calibrated … , our data strongly support the universal need for a booster …
ELISA kit controls were calibrated … , our data strongly support the universal need for a booster …
[HTML][HTML] Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices …
JL Liang - MMWR. Recommendations and reports, 2018 - cdc.gov
… a single dose of a tetanus toxoid, reduced diphtheria toxoid, and … and guidance for use are
described elsewhere in this report (see … Boostrix (GSK) is licensed by FDA as a single dose in …
described elsewhere in this report (see … Boostrix (GSK) is licensed by FDA as a single dose in …
Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with …
N Wanlapakorn, N Sarawanangkoor… - Human Vaccines & …, 2024 - Taylor & Francis
… 4 y, all groups were vaccinated with Tdap-IPV (Boostrix-polio, … second booster vaccine at 4
y of age was a reduced antigen … 11–18 y should receive a single dose of Tdap, preferably at a …
y of age was a reduced antigen … 11–18 y should receive a single dose of Tdap, preferably at a …
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children …
HJ Sharma, S Parekh, P Pujari, S Shewale… - … Review of Vaccines, 2023 - Taylor & Francis
… to receive a single dose of SIIPL Tdap or comparator Tdap vaccine (Boostrix®; GlaxoSmithKlines,
India… effectiveness (VE) after boosting with reduced antigen content, acellular pertussis-…
India… effectiveness (VE) after boosting with reduced antigen content, acellular pertussis-…